NFKB1 and systemic lupus erythematosus: As shown in Figure 6A, inhibition of proteosome degradation with LAC and IκB phosphorylation with BAY were similarly effective in blocking CD40-induced NF-κB signaling in B cells from lupus patients and normal controls.